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Summary. Because of reporting high side effects related to biosynthetic drugs, recent attention has been paid 
to the use of herbs instead of chemical drugs to balance serum lipids. The present systematic review aimed to 
evaluate the safety of herbal medicines and also to assess drug interaction in herbal therapy in treating hyperlip-
idemia. The international research databases including MEDLINE; Google scholar, Web of Science SciVerse 
Scopus (SCOPUS); EBSCO Academic Search; Cochrane Central Register of Controlled Trials (CENTRAL); 
and a Chinese database (China Network Knowledge Infrastructure [CNKI]) were searched from their respec-
tive inceptions up to September 2014  with the search terms of “hyperlipidemia”, “herbal medicine”, “medi-
cine traditional”, “extract plant”, “Traditional Medicine” and “Chinese Herbal Medicine” without narrowing 
or limiting search elements. A total of 85 randomized clinical trials (RCTs) studies were finally assessed on 
human subjects. A notable number of herbal drugs that are commonly used as an anti-hyperlipidemia agent 
may be interacted with a variety of biosynthetic drugs. In this regard, the most common reported herb-drug 
reactions were related to anticoagulants, antidepressants, anti-epileptic, anti-inflammatory, and/or even anti-
hypertension and anti-lipidemic drugs. Also, a considerable number of anti-lipidemic drugs of plants origin 
may be accompanied with metabolic disturbances and serious complications within pregnancy and breast feed-
ing. The main fundamental principles for administration of these drugs include physicians’ complete awareness 
of the effects and interactions of these drugs, educating people not taking these drugs arbitrarily, and closely 
monitoring the verification and distribution of the drugs in the society. (www.actabiomedica.it)
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Introduction
Ischemic heart disease as the most common cause 
for mortality and disabilities around the world is cer-
tainly triggered from a collection of potential risk fac-
tors that among these factors, dyslipidemia has been 
identified as the main arm for coronary atherosclerosis. 
The increase in the level of cholesterol, triglycerides, low 
density lipoprotein (LDL) and oxidized LDL particles 
and adversely the decrease in high density lipoprotein 
(HDL) particles in the bloodstream are strongly asso-
ciated with atheroma formation in the walls of arteries 
(atherosclerosis), which is the principal cause of coro-
nary artery disease. Several experimental, animal and 
interventional studies have indicated lower morbidity 
and mortality in coronary heart diseases with reduction 
of serum total cholesterol and improvement in HDL 
cholesterol (Pickin et al., 1999). Prevention or treat-
ment of such disorders can be achieved by targeting 
the causative factor for hyperlipidemia and hypercho-
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lesterolemia through diet and/or drug administration 
(Grundy et al., 2004; LaRosa, 1990). In this regard, 
lowering serum levels of cholesterol, triglycerides, and 
LDL as well as elevating HDL level is a main target 
for inhibiting progression of coronary artery disease 
and also for preventing its-related adverse and life-
threatening events. For this purpose, the principles of 
conventional treatment have been based on reducing 
cholesterol biosynthesis, which will lead to lower blood 
levels. A variety of biochemical drugs such as statins 
is available today which is involved in lowering cho-
lesterol biosynthesis in the liver; however as the late 
or high-dose using these agents, the administration 
of statins may result in increased risk of chronic toxic 
effects including carcinogenic, teratogenic, and muta-
genic changes over a lifetime of use (4-6). Because of 
reporting high side effects related to these biosynthe-
sis drugs, recent attention has been paid to the use of 
herbs instead of biosynthetic drugs to balance serum 
lipids (7). For many years, plants had been used for me-
dicinal aims. During 19th century, scientists tried to ex-
tract and amend the active ingredients from plants and 
started later making their own version of plant com-
pounds (8). Nowadays, plants are considered as impor-
tant sources of anti-hyperlipidemia treatment so that 
more than 80% of population of developing countries 
is dependent on traditional folk medicine therapies for 
treating their ailments (9). This fact has been recog-
nized by international societies and its recommenda-
tions include evaluation of traditional medicines in pri-
mary health care of these countries (10). In this regards, 
a large number of medicinal plants have been evaluated 
for their hypolipidemic activity and thus a lot of herbal 
drugs have been experimented in this aspect (11, 12), 
but the safety and efficacy of these herbal drugs remains 
ambiguous. In addition, there has been no comprehen-
sive evaluation of the clinical studies on the interaction 
between herbal and biosynthetic drugs. This systematic 
review of human source studies aimed to evaluate the 
safety of herbal medicines and also to assess drug in-
teraction in herbal therapy in treating hyperlipidemia.  
Methods
In the step of reviewing the literature, the follow-
ing databases were searched from their respective in-
ceptions up to September 2014: MEDLINE; Google 
scholar, Web of Science SciVerse Scopus (SCOPUS); 
EBSCO Academic Search; Cochrane Central Regis-
ter of Controlled Trials (CENTRAL); and a Chinese 
database (China Network Knowledge Infrastructure 
[CNKI]). No language restrictions were imposed. 
Dissertations and abstracts were included. The search 
terms were “hyperlipidemia”, “herbal medicine”, “med-
icine traditional”, “extract plant”, “ Traditional Medi-
cine” and “ Chinese Herbal Medicine” without nar-
rowing or limiting search elements. All of the human 
studies on the effects of herbs with the key outcome 
of change in lipid profiles were included. All human 
studies of the use of herbal medicines for hyperlipi-
demia were included. Thus, we focused on the patients 
(both children and adults) with clinical diagnoses of 
hyperlipidemia who met the diagnostic criteria of the 
American Heart Association guideline for hyperlipi-
demia. All studies that used herbal medicines or com-
bination therapy with conventional medicine versus 
placebo or other medications were included. Combi-
nations of herbal medicines and non-medicinal ther-
apy, such as acupuncture, and comparisons between 
different types of herbal medicines were excluded. We 
defined herbal medicines as product decoctions, con-
coctions, capsules, tablets, and powders that originated 
from botanical sources, such as whole plants or their 
adjuncts (13). The primary outcomes analyzed for 
the review included type of herbs, botanical sources, 
and common dosages of herbs used in trials. The sec-
ondary outcomes analyzed for the review were drug 
interactions with lipid-lowering herbs used. In final 
concluding, the safety of herbal drugs was discussed 
and appropriate instruction for using these drugs in 
combination with other drugs was presented. 
Results
Terms of use
Of the publications identified from the initial da-
tabase search, the results were identified and reviewed 
for inclusion or exclusion. A total of 85 randomized 
clinical trials (RCTs) studies were finally assessed on 
human subjects. The route of administration of herbs in 
almost all studies was oral intake. General and scientif-
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ic names of plants, root of administration, human doses 
limits and some precautions and side effects are sum-
marized in Table 1. Part of plants used as a therapeutic 
component was root of plant in Burdock, Chicory, Orchis, 
and Ginger; fruit in Black cherry, Avocado, Grape, Brin-
jal, Milk thistle, Olive, Apple, American peooer, Bilberry, 
Common wheat, Tomato, Cherry,  Haritali, Blackcurran, 
Coriander, Bitter orange christm lime, Orange, and Melon; 
seed in Pomegranate, Avocado, Blond plotitago, Grape, 
Milk thistle, Nutmeg, Oats, Soy, Fenugreek, Pumpkin, 
Bcack cumiv, Red yeast rice, Tamarind, Evening primrose, 
Dill, Corn, Comman bean, and Chickpea; leaf in Com-
mon Thyme, Aloe, Chamomile, Plantain, Chicory, Cab-
bage, Ginko, Thea, Olive, Purslane, Artichoke, Eugenol, 
Basil, Bulacy, Alfalfa, Dill, and Celery; flower in Yarrow, 
and Saf flower; onion in Onion and Garlic; gum in Gug-
gul; and rhizome in Ginseng and Miswak. The dose of 
administration varied Depending on the type of plant 
and root of administration from 100 mg to 200 grams. 
Contraindications and precautions
Regarding precautions, the use of some of the 
plants are prohibited during pregnancy and breast-
feeding including Common, Aloe, Chamomile, Burdock, 
Plantain, Nutmeg, Oats, Ginseng, Thea, Soy, Fenugreek, 
American peooer, Pumpkin, Yarrow, Bcack cumiv, Eugen-
ol, Guggul, Haritali, Evening primrose, Alfalfa, Dill, Saf 
flower, and Bitter orange christm lime. The appearance 
of allergic reactions especially dermatitis has been re-
ported following consumption of some types of plants 
including Brinjal, Chicory, and Artichoke. The precau-
tion in the use of Cabbage in hypertensive patients or 
those with hypothyroidism has been emphasized. Also, 
the use of Ginger in patients with cardiac arrhythmia 
is also prohibited. The use of Garlic and Bilberry is not 
recommended in patients with gastrointestinal prob-
lems and the use of Red yeast rice in those with liver 
diseases is also prohibited. The precaution in the use 
of Common wheat in Gluten Sensitivity, Comman bean 
in gout disease, and Celery in asthma is also pointed. 
Herb-drug interactions
As summarized in Table 2 and with respect to 
herb-drug interactions, some plants such as Grep ran-
som has interactions with some anti-epileptic, anti-
hypertension, and anti-lipidemic drugs leading in-
creased serum dosage of these drugs and create drug 
toxicity.  Avocado can be interacted with warfarin, and 
MAO Inhibitors. Pomegranate is interacted with anti-
hypertension, and anti-lipidemic drugs leading hy-
potension and increased the risk for rhabdomyolysis. 
Bilberry may be interacted with Aspirin, NSAIDS, 
Insulin, and anticoagulants led to increased risk for 
bleeding. The main interaction of Ginger with other 
drugs is generally related to antidepressants, anti-
arrhythmic drugs, and anticoagulants. Also, green tea 
may be interacted with adenosine, anti-androgens, 
theophylline, and some anticoagulants. Grape is only 
interacted with methotrexate result in increasing side 
effects of this drug. Psyllium is frequently interacted 
with anticoagulants, antidepressants, digoxin, car-
bamazepine, lithium and some diuretics and thus 
simultaneous use of these two drugs is not recom-
mended. The interaction between Saf flower and some 
synthetic drugs including aspirin, anticoagulants, and 
anti-hypertension drugs such as calcium-channel 
inhibitors has been also shown. Evening primrose 
oil may be interacted with a variety of drugs such 
as analgesics, anti-epileptic drugs, MAO inhibitors, 
antipsychotic drugs, and even statins. Celery is fre-
quently interacted with ACE inhibitors, alcohol, and 
anticoagulants. The main interaction between Yar-
row and other drugs is specified to the drugs used in 
the treatment of photo-dermatitis leading increase of 
photosensitivity. The use of Dandelion may be led to 
interaction with metronidazol. Also, the use of Cab-
bage may be interacted with acetaminophen, and vi-
tamin K antagonists. Ginko is mainly interacted with 
anticoagulants, anti-epileptic drugs, MAO inhibitors, 
and antidepressants. Ginseng can be interacted with 
anti-hypertension drugs, digoxin, steroidal drugs, 
immunosuppressive drugs, and hypnotics. Blueberry 
is usually interacted with some antibiotics, insulin, 
metronidazole, anti-acids, and proton-pump inhibi-
tors. Also, those studies which assessed interaction of 
Thyme with other drugs have suggested its interaction 
with 5-Fluorourasil, fluoroquinolones, amphotericin, 
leishmaniasis drugs, thyroid drugs, caffeine, hormonal 
drugs, hydrocortisone, hydrophilic drugs, and immu-
nosuppressive drugs.   
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Table 1 
General name  Scientific name Part of plant Dose limits  Precautions 
Black cherry Prunus cerasus Fruit  20/d --
Pomegranate Punica gra natcm Seed 8 g/d --
Avocado Persea ameri cana Seed , Fruit 8 g/d --
Common Thyme Thymus volgaris Leaf  2 g Prohibited in pregnancy 
Blond plotitago Plantago ovate Seed 7.5 g --
Aloe Aloe vera Leaf 5 Prohibited in pregnancy 
Grape Vitis uinifera Fruit , Seed 100 mg --
Chamomile Matricaria recutita Leaf 2-8 g Prohibited in pregnancy 
Burdock Arctium Loppa Root  2-6 g Prohibited in pregnancy 
Brinjal Solanum melongena Fruit 3/d Allergic effects
Milk thistle Sipybum marinum Fruit , Seed 12 g --
Plantain Plantago Lanceolata Leaf , Seed 5 g Prohibited in pregnancy 
Chicory Chicorium Lntybus Root, Leaf 3-5 g Dermatitis susceptibility
Onion Allium cepa Onion  20 g --
Cabbage Brassica oleracea Leaf 10 g In hypertension and hypothyroidism
Orchis Orchis latifolia Root 1 g --
Nutmeg Miristica fragrans Seed  500 mg Prohibited in pregnancy 
Oats Avena sativa Seed  100 g Prohibited in pregnancy 
Ginseng Eleuthero coccus  Rhizome  1 g Prohibited in pregnancy 
Ginko Ginko biloba Leaf  240 mg --
Thea Thea sinesis Leaf  7 g Prohibited in pregnancy 
Ginger Zingiber off icinalis Root 2-4 g Cardiac arrhythmia
Olive Olea europea Leaf , Fruit 7-8 g --
Soy Glycine soja Seed 45 g Prohibited in pregnancy 
Apple Malus orientalis Fruit 1/d --
Garlic Allium sativum Onion  1 g GI problems
Fenugreek Trigonella foenum  Seed 5 g Prohibited in pregnancy 
American peooer Capsicum frutescens Fruit 4/d Prohibited in pregnancy 
Bilberry Vaccinium myrtillus Fruit 5 g/d GI problems
Purslane Poryulaca oleracea Leaf 100 g --
Pumpkin Cucurbita pepo Seed 10-20 g Prohibited in pregnancy 
Yarrow Achillea wilhelmsii Flower  4 g Prohibited in pregnancy 
Common wheat Triticum aestivum Fruit 30-80 g Gluten sensitivity
Tomato Solanum lycopersicum Fruit 100 g --
Cherry Prunus avium Fruit 100 g --
Artichoke Cynara cardunculus Leaf 1-9 g Dermatitis susceptibility
Bcack cumiv Nigella sativa Seed 1.5 g Prohibited in pregnancy 
Eugenol Eugenia jambolana Leaf 2 g Prohibited in pregnancy 
Miswak Musa paradisiaca Rhizome 2 g --
Guggul Commiphora mukul Gum  100 mg Prohibited in pregnancy 
Red yeast rice Monascus purpureus Seed  1.2-2.4 g Liver disease
Tamarind Tamarindus indica Seed  10 g Prohibited in pregnancy 
Basil Ocimum basilicom Leaf  12 g --
Bulacy Osmium sanctum Leaf  10 g --
Haritali Terminalia chebula Fruit 1-3 g Prohibited in pregnancy 
Blackcurran Vitis vinifera Fruit 10 g --
Evening primrose Oenothera biennis Seed 4 g/d Prohibited in pregnancy 
Alfalfa Medicago sativa Leaf 5-10 g Prohibited in pregnancy 
Dill Anethum graveolens Seed, Leaf 10 g Prohibited in pregnancy 
Walnut Juglans regia Core  80 g --
Coriander Coriandrum sativam Fruit 1-10 g -
Saf flower Carthamus tinctorius Flower  3-5 g Prohibited in pregnancy 
Corn Zea mays Seed  20 g --
Comman bean Pnaseolus unlgaris Seed  100 g Gout 
Chickpea Cicer arientinum Seed  150 g --
Bitter orange christm lime Citrus aurantifolia Fruit 20 g Prohibited in pregnancy 
Orange Citrus aurantium Fruit 4/d --
Celery Apium graveolens Leaf  2 g/d Asthma 
Melon Cucumis melo L Fruit  20/d --
05-roohi borojeni.indd   133 11/09/15   11:10
Ha. Roohi Borojeni, Ho. Roohi Borojeni, M. Gharipour, et al.134
Table 2.  
Name of plant Name of drug Interaction  Result 
Grep ransom Amiodarone  Increase of plasma level Toxicity, decrease of blood pressure
 Quinidine Decrease of absorption  
 Carbamazepine  Increase of AUC Toxicity symptoms of drug 
 Sertraline Increase of plasma level Increase of drug side effects
 Trazodone 
 Nefazodone 
 Clomipramine  
 Caffeine  Decrease of clearance  Increase of insomnia and irritability 
 Nitrates  Increase of plasma level Increase of drug side effects 
 Statins  Increase of plasma level Increase of drug side effects (muscular pain)
 Cyclosporine Increase of plasma level Hepatic and renal toxicity 
 Tacrolimus Increase of plasma level Renal toxicity 
Avocado Warfarin Decrease of absorption Decrease of drug effect
 MAO Inhibitors Thiamine release  Hypertension crisis 
Pomegranate Statins  Increase of creatine kinase  Increased rhabdomyolysis
 ACE inhibitors  Inhibition of I to II converter Hypotension 
Bilberry Aspirin, NSAIDS Thromboxane inhibition  Risk of bleeding 
 Insulin  Secretion stimulation  Hypoglycemia 
 Supplementation  Increase of plasma level Toxicity with chromium
 with chromium 
 Plavix, ticlopidine  Anti-platelet aggregation  Anticoagulant reactions 
Ginger SSRIs Serotonin antagonist Changes in drug effect 
 Anti-arrhythmic drugs Increase of Ca2t ATPase  Changes in drug effect
 Anticoagulants  Inhibition of thromboxane B2 Increase of drug effects 
 Benzodiazepines Increase of GABA Sleepiness 
 Quinidine Increase of Ca2t ATPase  Drug toxicity 
Green tea  Adenosine Caffeine antagonist  Changes in drug effect 
 Anti-androgens  Inhibition of drug metabolism Increase of drug effects
 Theophylline  Decrease of clearance  Increase of drug side effects 
 Coumarin  Vit K antagonist effect Decrease of warfarin effects
 anticoagulants   
Grape Methotrexate Inhibition of xanthine oxidase Increase of drug side effects 
Psyllium Anticoagulants  Decrease of absorption Increase of drug side effects 
 Tricyclic  Decrease of absorption Increase of drug side effects 
 antidepressants
 Anti-diarrheal Fecal bulking Increase of drug side effects 
 Carbamazepine Decrease of absorption Increase of drug side effects 
 Digoxin Decrease of absorption Decrease of daily dose of drug 
 Diuretics  Decrease of absorption Increase of drug side effects 
 Lithium  Decrease of absorption Increase of drug side effects 
Saf flower Anticoagulants Anti-platelet aggregation  Anticoagulant reactions 
 Aspirin  Increase of drug effects Increase of drug side effects 
 Ca-channel blockers  Microcirculation increasing  Increase of drug side effects 
Evening primrose oil Analgesics  Probability of seizure  Increase risk of seizure 
 Anti-epileptics  Reduce the threshold neurons High risk in patients with epilepsy 
 Phenothiazines Probability of seizure  Increase risk of seizure 
 Statins  Inhibition of cholesterol production Decrease of statin effects on lipids 
Celery  ACE inhibitors  Allergic sensitivity  Allergic sensitivity and anaphylaxis shock  
 Alcohol  Allergic sensitivity  Allergic sensitivity and anaphylaxis shock  
 Sedatives  Increase the effects of N-butyl Sleepiness 
  phthalide
 Anticoagulants Increase of drug effects  Increase of drug side effects 
(continued)
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Discussion
As pointed in our study results, a notable number 
of herbal drugs that are commonly used as an anti-
hyperlipidemia agent may be interact with a variety of 
biosynthetic drugs. In this regard, the most common 
reported herb-drug reactions were related to anticoag-
ulants, antidepressants, anti-epileptic, anti-inflamma-
tory, and/or even anti-hypertension and anti-lipidemic 
drugs. Therefore, most recommended precautions 
should be focused on concurrently use of these anti-
lipidemic herbal agents and other drugs with high cau-
tion and with considering their synergetic effects. As 
an applied guideline for internists to administer herbal 
drugs for treating hyperlipidemia, the following rec-
ommendations can be pointed: First, a number of anti-
lipidemic drugs of plants origin may be accompanied 
with metabolic disturbances and serious complications 
within pregnancy and breast feeding that thus their 
administration should be performed with full knowl-
edge of their side effects in these periods. Second, some 
herbal drugs including Avocado, Bilberry, Ginger, Green 
tea, Psyllium, Saf flower, Celery, and Cabbage should be 
cautiously used in patients with coagulation disorders, 
as well as in those with the history of cardiovascular 
and or cerebrovascular disorders. Moreover, because of 
the direct interactions of some plants including Grep 
ransom, Bilberry, Ginger, Psyllium with cardiovascular 
medications such as digoxin, anti-arrhythmic drugs, 
or inotropes, the use of this agents in cardiovascular 
Table 2.  
Name of plant Name of drug Interaction  Result 
Yarrow Photodermatitis drugs Increase of photosensitivity  Side effects of photosensitivity
Dandelion Metronidazole  Disulfiram-like reaction Nausea 
Cabbage Acetaminophen  Increase of metabolism  Decrease of drug effects 
 Vitamin K antagonist  Increase of Vitamin K Toxicity with Vitamin K
Ginko Anticoagulants Anti-platelet aggregation  Anticoagulant reactions 
 Antiepileptic drugs   Probability of seizure  Increase risk of seizure 
 MAO Inhibitors Serotonin release  Serotonin syndrome 
 SSRIs Serotonin release  Serotonin syndrome 
Ginseng  Anti-hypertensions  Increase of vascular resistance   Hypertension
 Digoxin Increase of drug effects Drug toxicity
 Estrogenic drugs   Estrogen- 3- sulfate inhibition Estrogen inhibition 
 Immunosuppressive Stimulating the immune Stimulating the immune reactions
 Hypnotics  Deeping sleep Nervous sleepiness 
Blueberries Amoxicillin  Increase of drug effects  Anti-H.pylori effects
 Omeprazole 
 Clarithromycin 
 Insulin  Hypoglycemia  Hypoglycemia
 Metronidazole Disulfiram-like reaction Nausea 
 Anti-acids  Decrease of gastric PH GI complications
 Omeprazole  
Thyme 5-Fluorourasil Increase of skin absorption Increase of skin absorption
 Fluoroquinolones  Decrease of drug effects  Susceptibility to infection
 Amphotericin B Decrease of drug effects  Susceptibility to fungal infection
 Anti-Leishmaniasis  Increased drug effects due to the Increase of drug effects
 and Entamoeba drugs presence of thymol 
 Anti-thyroid drugs Decrease of TSH Hyperthyroidism 
 Caffeine  Reduce the release of thymol Decrease of the effect of caffeine 
 Hormonal drugs  Increased estrogen and  Anti-testosterone effects 
  progesterone effects
 Local hydrocortisone  Increased skin penetration of Increase of drug effects
  hydrocortisone
 Hydrophilic  Drugs Increased skin penetration  Increase of drug effects
 Immunosuppressive  Stimulation of the increase of Immunosuppression
  superoxide production
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disease states should be programmed with a deep and 
extensive study on their effects and drug interactions 
in these patients. In this regard, the use of some other 
herbal drugs such as Bilberry and Blueberries should be 
considered with high precaution. 
This systematic review attempted to appraise the 
quality, efficacy/effectiveness, and safety of herbals used 
to treat hyperlipidemia. It indicated that there are herb-
als that have shown positive results via clinical trials for 
the treatment of hyperlipidemia that are available on 
the market today. However, most of these drugs may 
not be approved by scientific sources and thus may be 
administered traditionally that is very common in some 
societies such as our society. On the other hand, there 
are some traditional ideas and experiences in effective-
ness of these herbs without considering their serious 
side effects. More and more studies are being dedicated 
to the effectiveness of herbs, and though some ailments 
are too severe or complicated to be treated without 
the consultation of a doctor or hospital, many people 
choose to try herbal remedies first in order to be eco-
nomical and healthy. In addition, some types of herbal 
drugs may be commonly used without having a careful 
history of the patient records leading serious and even 
life-threatening consequences. Thus, the main funda-
mental principles for administration of these drugs 
include physicians’ complete awareness of the effects 
and interactions of these drugs, educating people not 
taking these drugs arbitrarily, and closely monitoring 
the verification and distribution of the drugs in the 
society. Also, while it is recommended that doctors 
be consulted before integrating herbal remedies into a 
daily regimen or treating a condition, most herbs are 
self-explanatory, as they give dosage instructions and 
recommended length of ingestion on the labels.  
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